lercanidipine
chemical compound
≈ 1 min read
lercanidipine. encyclopegia.org, snapshot lercanidipine-047469-2eade6367567e88e. /a/lercanidipine
Names in other languages
- Englishlercanidipine
- Françaislercanidipine
- Italianolercanidipina
- Nederlandslercanidipine
- Polskilerkanidypina
- DeutschLercanidipin
- shLerkanidipin
- СрпскиLerkanidipin
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Lercanidipine (INN) is an antihypertensive (blood pressure lowering) drug. It belongs to the dihydropyridine class of calcium channel blockers, which work by relaxing and opening the blood vessels allowing the blood to circulate more freely around the body. This lowers the blood pressure and allows the heart to work more efficiently.
This drug (trade name Zanidip, among others) acts more slowly than older dihydropyridines. It probably has fewer adverse effects, but a comparatively high potential for drug interactions. It was patented in 1984 and first approved for medical use in 1997.
The FDA refused to approve the drug, and lercanidipine is not marketed in the United States.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1334409442 under CC BY-SA 4.0; modifications have been made.